Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 570 results for "Shionogi"

Lupin buys 21 drugs from Japan's Shionogi to expand its generic portfolio
International Business Times India

SHIONOGI : Lupin to buy 21 products of Japan`s Shionogi for Rs...

Kyowa Pharmaceutical Industry, drug major Lupin`s Japanese subsidiary, has inked a pact to acquire 21 products from Shionogi & Co for 15.4 billion yen (around Rs 1,000 crore), paving the way for the homegrown firm to enter Japan`s branded ... 4 Traders, 1 week ago

Edited Transcript of 4507.T earnings conference call or presentation 1-Aug-16 10:59am GMT

Q1 2017 Shionogi & Co Ltd Earnings Call Osaka Aug 18, 2016 (Thomson StreetEvents) -- Edited Transcript of Shionogi & Co Ltd earnings conference call or presentation Monday, August 1, 2016 at 10:59:00am GMT TEXT version of Transcript ...
 Yahoo! Finance1 month ago BRIEF-Shionogi & Co says sales transfer of 21 product and tansfer of manufacturing and marketing approval  Reuters UK1 month ago SHIONOGI & CO LTD : quaterly earnings release  4 Traders2 months ago Edited Transcript of LUPIN.NSE earnings conference call or presentation 9-Aug-16 10:30am GMT  Yahoo! Finance1 month ago

Lupin's subsidiary enters into agreement with Shionogi & Co.

The article below represents a preview only and is not meant for reuse or republishing. India, Aug. 2 -- Pharma Major Lupin Limited has said that its Japanese subsidiary Kyowa Pharmaceutical Industry Co., Ltd. has entered into a strategic asset ...
 HT Syndication1 month ago Top 14 stocks in focus: Lupin, Tech Mahindra, IndiGo  India Infoline1 month ago

Investment strategies: 2 'must have' stocks in your portfolio

- By Bank of America Merrill Lynch reiterates buy call on Lupin with target at Rs 1950 per share as Shionogi portfolio acquisition marks entry into Japanese
 Moneycontrol.com1 month ago

Lupin expands Japan business with Rs 1,000 crore buy

Lupin has acquired the branded drug portfolio of Japanese pharma company Shionogi for about Rs 1,000 crore, expanding its presence in the market. Japan accounts for about 10 per cent of Lupin's revenue and is its third biggest market after the US ...
 Business Standard India1 month ago

Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brands

MUMBAI: Lupin, India's third-largest drugmaker, is in talks with Japan's Astellas and Shionogi to buy the off-patent medicine brands they have separately put on the block, two people aware of the development said. The basket of drugs that Astellas ...
 Economic Times2 months ago Deals Buzz: Fosun to buy Gland Pharma for $1.3 billion  Livemint.com2 months ago

Naldemedine Phase III Study Demonstrates Long-Term Safety And Efficacy For The Treatment Of Opioid-Induced Constipation

OSAKA, Japan and FLORHAM PARK, N.J., Sept. 7, 2016 /PRNewswire/ -- Shionogi today presented positive results of a 52-week, placebo-controlled, phase III study (COMPOSE III) of naldemedine in treating opioid-induced constipation (OIC) in patients ...
 4 Traders2 weeks ago Shionogi Release: Naldemedine Phase III Study Demonstrates Long-Term Safety And Efficacy For The Treatment Of Opioid-Induced Constipation  BioSpace2 weeks ago COMPOSE III: Naldemedine safe for long-term treatment of OIC  Healio2 weeks ago Opioid Induced Constipation Treatment Market to Touch US$4.8 bn by 2023, Mu-opioid Receptor Antagonist to be Fastest-growing Segment  PharmiWeb2 weeks ago

Shionogi Presents Results from a Phase 2 Proof-of-Concept Clinical Trial and Non-Clinical Studies of S-033188, a Novel Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza

OSAKA, Japan, Aug. 28, 2016 /PRNewswire/ -- Shionogi & Co., Ltd. (hereafter "Shionogi") reported clinical and non-clinical data for S-033188, a cap-dependent endonuclease inhibitor targeting influenza. In a Phase 2 proof-of-concept study, one-day, ...
 4 Traders1 month ago

SHIONOGI : Patent Issued for Preparation for Improving Solubility of Poorly Soluble Drug (USPTO 9427402)

By a News Reporter-Staff News Editor at Drug Week -- A patent by the inventors Sakuma, Satoshi (Amagasaki, JP); Ueda, Hiroshi (Toyonaka, JP); Mashimo, Akira (Amagasaki, JP); Murazato, Hiroshi (Osaka, JP), filed on September 29, 2011, was published ...
 4 Traders2 weeks ago

Indian generics manufacturer Lupin buys 21 brands from Japan's Shionogi

India's third biggest drug producer Lupin Ltd (Lupin) has announced that it will purchase 21 generic medicine brands from Japanese company Shionogi & Co Ltd (Shionogi) for a total of US$150 million, bolstering its position in the large Japanese ...
 GaBi Online3 weeks ago LUPIN : buys 21 branded products from Shionogi for $ 150 mn  4 Traders1 month ago Lupin buys 21 branded products from Shionogi for $ 150 mn [DealCurry (India)]  Pharmacy Choice1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less